Imunon, Inc. IMNN 深 沪
已收盘 07-02 16:00:00 美东时间
1.91
+0.030
+1.60%
华盛通- 最 高1.94
- 今 开1.87
- 成交量 3.19万股
- 最 低 1.81
- 昨 收 1.88
- 总市值 802.60万
- 52周最高 10.3956
- 市盈率 静 --
- 换手率 0.76%
- 52周最低 1.70
- 委 比 37.96%
- 总股本 420.21万
- 历史最高 25857.3851
- 量 比 0.49
- 振 幅 6.91%
- 历史最低 1.70
- 每 手 1
- 风险率 1.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多IMUNON Receives Independent Data Monitoring Committee Recommended Continuation Of Pivotal Phase 3 OVATION 3 Clinical Trial Of IMNN-001 In Combination With Standard Of Care Neoadjuvant And Adjuvant Chemotherapy In Women With Newly Diagnosed Advanced Ovarian Cancer
IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the independent Data Monitoring Committee (iDMC) has recommended continuation of the pivotal Phase 3 OVATION 3 clinical trial evaluating IMNN-001 in combination with ...
06-23 20:03
IMUNON Enters Into Definitive Agreements For $10M In Preferred Stock And Secured Notes
Includes up-front issuance of preferred stock for $2.5 million and secured promissory notes for $7.72 millionUniquely structured, flexible financing supports IMUNON's Highly Anticipated Phase 3 OVATION 3 Study of
06-04 20:04
Imunon Reports Q1 2026 Results: Full Earnings Call Transcript
Imunon (NASDAQ:IMNN) released first-quarter financial results and hosted an ear...
05-12 23:54
Imunon Q1 EPS $(0.84) Beats $(1.07) Estimate
Imunon (NASDAQ:IMNN) reported quarterly losses of $(0.84) per share which beat the analyst consensus estimate of $(1.07) by 21.5 percent. This is a 73.33 percent increase over losses of $(3.15) per share from the same
05-12 20:01
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
美股大行评级 | 美银证券上调闪迪目标价从900美元升至1080美元；纽约梅隆银行、Onto Innovation、安博、美国合众银行等获多家大行上调目标价
今日重点评级关注：Guggenheim：维持AtaiBeckley Inc."买入"评级，目标价从11美元升至16美元；RBC Capital：维持MeiraGTx Holdings"跑赢大市"评级，目标价从16美元升至24美元
04-20 11:33
Maxim Group Initiates Coverage On Imunon with Buy Rating, Announces Price Target of $10
Maxim Group analyst Jason McCarthy initiates coverage on Imunon (NASDAQ:IMNN) with a Buy rating and announces Price Target of $10.
04-17 21:18
Imunon Q4 EPS $(1.30) Misses $(1.13) Estimate
Imunon (NASDAQ:IMNN) reported quarterly losses of $(1.30) per share which missed the analyst consensus estimate of $(1.13) by 15.04 percent. This is a 56.67 percent increase over losses of $(3.00) per share from the same
03-31 20:12
Earnings Scheduled For March 31, 2026
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
Watching Imunon; Zacks Small-Cap Research Gives Stock $33 Price Valuation
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03252026_IMNN_Bautz.pdf
03-25 23:11
